Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Agamree 40 mg/ml oral suspension {equilateral_black_triangle}

Active Ingredient:
vamorolone
Company:  
Santhera (UK) Limited See contact details
ATC code: 
H02AB18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Patient Alert Card

Patient Alert Card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Santhera (UK) Limited
Company image
Address
1 Chamberlain Square Cs, Birmingham, B3 3AX, UK
E-mail
[email protected]
Medical Information e-mail
[email protected]